Compounds > 4-amino-1,8-naphthalimide
Page last updated: 2024-10-21

4-amino-1,8-naphthalimide and Alloxan Diabetes

4-amino-1,8-naphthalimide has been researched along with Alloxan Diabetes in 2 studies

4-amino-1,8-naphthalimide: inhibits ADP-ribosylation; sometimes abreviated as 4-AN;

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Negi, G1
Kumar, A2
Sharma, SS2
Kaundal, RK1

Other Studies

2 other studies available for 4-amino-1,8-naphthalimide and Alloxan Diabetes

ArticleYear
Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
    Biochemical and biophysical research communications, 2010, Jan-01, Volume: 391, Issue:1

    Topics: 1-Naphthylamine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; DNA Damage; Male;

2010
Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy.
    Life sciences, 2008, Mar-12, Volume: 82, Issue:11-12

    Topics: 1-Naphthylamine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Humans; Male; NAD;

2008